Article Abstract

The emerging role of sST2 blocking in the therapy of graft-versushost disease

Authors: Yifan Xiao, Fang Zheng

Abstract

Suppression of tumorigenicity 2 (ST2) is an interleukin-1 (IL-1) receptor family member with transmembrane (mST2) and soluble isoforms (sST2) (1).

Refbacks

  • There are currently no refbacks.

Article Options

Download Citation